|
Volumn 62, Issue 16, 2002, Pages 4592-4598
|
Doxorubicin treatment in vivo causes cytochrome c release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
8 ISOPROSTAGLANDIN F2 ALPHA;
ANTHRACYCLINE DERIVATIVE;
ANTINEOPLASTIC ANTIBIOTIC;
CASPASE 3;
COPPER ZINC SUPEROXIDE DISMUTASE;
CYTOCHROME C;
DOXORUBICIN;
PROTEIN BAX;
PROTEIN BCL 2;
TROPONIN T;
ANIMAL CELL;
ANIMAL MODEL;
APOPTOSIS;
ARTICLE;
CANCER CHEMOTHERAPY;
CARDIOTOXICITY;
CONTROLLED STUDY;
ENZYME ACTIVITY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HEART MITOCHONDRION;
HEART MUSCLE CELL;
HEART WEIGHT;
MALE;
NONHUMAN;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
PROTEIN CONTENT;
RAT;
AMINO ACID SEQUENCE;
ANIMALS;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTIOXIDANTS;
APOPTOSIS;
BCL-2-ASSOCIATED X PROTEIN;
BODY WEIGHT;
CYTOCHROME C GROUP;
DOXORUBICIN;
HEART;
INTRACELLULAR MEMBRANES;
IRON;
MALE;
MITOCHONDRIA, HEART;
MOLECULAR SEQUENCE DATA;
MYOCARDIUM;
ORGAN SIZE;
OXIDATIVE STRESS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
RATS;
RATS, SPRAGUE-DAWLEY;
SUPEROXIDE DISMUTASE;
|
EID: 0037102148
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (396)
|
References (39)
|